摘要:
The present invention relates to a novel chlorin e6-folic acid conjugate, a preparation method thereof, and a pharmaceutical composition for the treatment of cancer comprising the same, and more particularly, to a novel compound prepared by linking chlorin e6 to folic acid, which effectively produces singlet oxygen in various media and has much better tumor selectivity than the known porphyrin-based photosensitizers, thereby being used effectively in photodynamic therapy for malignant tumors, a preparation method thereof, and a pharmaceutical composition for photodynamic treatment of solid tumors comprising the compound.
摘要:
The present invention relates to a pharmaceutical composition for the treatment of cancer comprising a chlorin e6-folic acid conjugate compound and chitosan, and more particularly, to a pharmaceutical composition for photodynamic therapy of solid tumors comprising the novel chlorin e6-folic acid conjugate compound or a pharmaceutically acceptable salt thereof and chitosan, in which the novel compound is prepared by linking chlorin e6 to folic acid, and effectively produces singlet oxygen in various media and has much better tumor selectivity than the known porphyrin-based photosensitizers, thereby being used effectively in photodynamic treatment for malignant tumors.
摘要:
The present invention relates to an agent for controlling Bcl-2 expression comprising ginsenoside F1 (20-O-β-D-glucopyranosyl-20(S)-protopanaxatriol) represented by the following formula 1 as an active component. [Formula 1]
摘要:
Disclosed is a pharmaceutical composition for treating and preventing metabolic bone diseases, comprising a pharmaceutically effective amount of N-acylated lysophosphatidylcholine compound represented by Formula 1 (R is a saturated or unsaturated fatty acid of C14 to C20, and R′ is methoxycarbonyl or hydroxylmethyl group), and a pharmaceutically acceptable carrier. Also, the present invention discloses a method of preparing an N-acylated lysophosphatidylcholine compound represented by Formula 1, from serine. [Formula 1]
摘要:
Disclosed is a method for generating and authenticating a three-dimensional dynamic OTP that does not require input of a password. In the method, a user address received from a user terminal is converted into coordinate values in degrees, minutes, and seconds on latitude and longitude, and set as address coordinates from the coordinates in a unit of seconds and then a two-dimensional reference coordinate system is displayed that is subdivided with the address coordinates as an origin, a two-dimensional function is provided and rotated about an arbitrary axis to form a three-dimensional space by a three-dimensional function, one OTP generation coordinate within the three-dimensional space is provided, and then a one-time password is generated by combining respective coordinate values of x, y, and z axes of the one OTP generation coordinate.
摘要:
Disclosed are a composition for inhibiting the expression of GA733-2 or for detecting GA733-2, which comprises TREM-2 gene or protein, a transgenic animal containing same, and a method using the same.
摘要:
Disclosed is a single or multi-route map matching apparatus in a system which provides a navigation service via a mobile communication terminal. The map matching apparatus comprises: an information center for calculating an optimum route to a destination inputted by a user based upon a present location of the mobile communication terminal, and generating a format of route data based upon the calculated optimum route; and an Intelligent Transportation System (ITS) terminal for detecting the present location of the mobile terminal to generate location data, processing the route data, performing map matching based upon the location data to determine whether the user travels on a given route or departs from the route, and performing road guidance based upon a result of the map matching.
摘要:
The present invention relates to a novel chlorin e6-folic acid conjugate, a preparation method thereof, and a pharmaceutical composition for the treatment of cancer comprising the same, and more particularly, to a novel compound prepared by linking chlorin e6 to folic acid, which effectively produces singlet oxygen in various media and has much better tumor selectivity than the known porphyrin-based photosensitizers, thereby being used effectively in photodynamic therapy for malignant tumors, a preparation method thereof, and a pharmaceutical composition for photodynamic treatment of solid tumors comprising the compound as an active ingredient.
摘要:
The present invention relates to an agent for controlling Bcl-2 expression comprising ginsenoside F1 (20-O-β-D-glucopyranosyl-20(S)-protopanaxatriol) represented by the following formula 1 as an active component.
摘要:
Disclosed is a telematics system comprising a telematics terminal for storing complex intersection images and providing information related to a present position and a running direction by using the complex intersection images, and a telematics server for sharing ID codes of the complex intersection images stored in the telematics terminal with the telematics terminal and creating route data in response to a request from the telematics terminal, wherein the telematics server adds the ID codes of the complex intersection images to the route data when the route data include complex intersections and transmits the ID codes of the complex intersection images and the route data to the telematics terminal. The telematics system provides route information, which is easily recognized by users.